Kodiak Sciences (KOD) Competitors $6.40 -0.40 (-5.88%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$6.40 0.00 (0.00%) As of 01/31/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KOD vs. EVO, KNSA, MRVI, VIR, NRIX, DYN, SPRY, XNCR, PRAX, and ARDXShould you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Evotec (EVO), Kiniksa Pharmaceuticals (KNSA), Maravai LifeSciences (MRVI), Vir Biotechnology (VIR), Nurix Therapeutics (NRIX), Dyne Therapeutics (DYN), ARS Pharmaceuticals (SPRY), Xencor (XNCR), Praxis Precision Medicines (PRAX), and Ardelyx (ARDX). These companies are all part of the "pharmaceutical products" industry. Kodiak Sciences vs. Evotec Kiniksa Pharmaceuticals Maravai LifeSciences Vir Biotechnology Nurix Therapeutics Dyne Therapeutics ARS Pharmaceuticals Xencor Praxis Precision Medicines Ardelyx Kodiak Sciences (NASDAQ:KOD) and Evotec (NASDAQ:EVO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking and valuation. Does the media favor KOD or EVO? In the previous week, Evotec had 2 more articles in the media than Kodiak Sciences. MarketBeat recorded 4 mentions for Evotec and 2 mentions for Kodiak Sciences. Evotec's average media sentiment score of 0.71 beat Kodiak Sciences' score of 0.44 indicating that Evotec is being referred to more favorably in the news media. Company Overall Sentiment Kodiak Sciences Neutral Evotec Positive Do analysts recommend KOD or EVO? Kodiak Sciences presently has a consensus price target of $8.00, suggesting a potential upside of 25.00%. Evotec has a consensus price target of $5.93, suggesting a potential upside of 31.27%. Given Evotec's higher possible upside, analysts clearly believe Evotec is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Evotec 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, KOD or EVO? Kodiak Sciences has a beta of 2.11, suggesting that its stock price is 111% more volatile than the S&P 500. Comparatively, Evotec has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Is KOD or EVO more profitable? Evotec's return on equity of 0.00% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -84.52% -45.40% Evotec N/A N/A N/A Which has better valuation & earnings, KOD or EVO? Evotec has higher revenue and earnings than Kodiak Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$260.49M-$3.65-1.75Evotec$845.74M1.89-$90.82MN/AN/A Do institutionals & insiders hold more shares of KOD or EVO? 89.1% of Kodiak Sciences shares are held by institutional investors. Comparatively, 5.8% of Evotec shares are held by institutional investors. 45.3% of Kodiak Sciences shares are held by insiders. Comparatively, 1.0% of Evotec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in KOD or EVO? Kodiak Sciences received 13 more outperform votes than Evotec when rated by MarketBeat users. However, 54.55% of users gave Evotec an outperform vote while only 27.54% of users gave Kodiak Sciences an outperform vote. CompanyUnderperformOutperformKodiak SciencesOutperform Votes1927.54% Underperform Votes5072.46% EvotecOutperform Votes654.55% Underperform Votes545.45% SummaryEvotec beats Kodiak Sciences on 8 of the 12 factors compared between the two stocks. Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOD vs. The Competition Export to ExcelMetricKodiak SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$355.21M$3.05B$5.58B$9.12BDividend YieldN/A1.84%5.31%3.99%P/E Ratio-1.7536.8280.0317.24Price / SalesN/A319.021,259.7283.26Price / CashN/A190.0245.9637.70Price / Book1.264.125.124.70Net Income-$260.49M-$40.99M$111.40M$224.47M7 Day Performance-20.10%-0.43%2.30%-0.19%1 Month Performance-35.68%0.94%3.13%0.57%1 Year Performance45.79%-1.69%24.60%20.35% Kodiak Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KODKodiak Sciences3.6012 of 5 stars$6.40-5.9%$8.00+25.0%+59.6%$355.21MN/A-1.7590Short Interest ↑Gap DownEVOEvotec1.7653 of 5 stars$4.34+0.8%$5.93+36.9%-41.6%$1.53B$845.74M0.005,061Short Interest ↑News CoverageKNSAKiniksa Pharmaceuticals3.7505 of 5 stars$20.62+2.9%$36.60+77.5%+11.2%$1.49B$270.26M-147.24220Short Interest ↓MRVIMaravai LifeSciences4.6307 of 5 stars$5.60-0.4%$10.28+83.8%-15.0%$1.41B$288.95M-3.41610Insider TradeVIRVir Biotechnology3.9433 of 5 stars$10.23-3.8%$34.83+240.6%+10.6%$1.40B$86.18M-2.60580Analyst ForecastShort Interest ↑Analyst RevisionNRIXNurix Therapeutics2.2945 of 5 stars$19.47-2.3%$30.35+55.9%+149.5%$1.39B$76.99M-6.72300Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageDYNDyne Therapeutics3.8989 of 5 stars$13.68-0.3%$49.91+265.0%-33.6%$1.38BN/A-3.81100High Trading VolumeSPRYARS Pharmaceuticals2.931 of 5 stars$14.23+1.1%$26.00+82.7%+109.7%$1.37B$30,000.00-27.7290XNCRXencor4.3154 of 5 stars$19.10-2.8%$34.88+82.6%-2.2%$1.33B$168.34M-5.95280Short Interest ↑News CoveragePRAXPraxis Precision Medicines2.2234 of 5 stars$71.58-7.2%$149.11+108.3%+75.5%$1.33B$2.45M-6.92110Short Interest ↑ARDXArdelyx4.6432 of 5 stars$5.54+0.3%$9.42+70.1%-38.6%$1.31B$124.46M-18.4490Analyst UpgradeInsider Trade Related Companies and Tools Related Companies EVO Competitors KNSA Competitors MRVI Competitors VIR Competitors NRIX Competitors DYN Competitors SPRY Competitors XNCR Competitors PRAX Competitors ARDX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KOD) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
